WA
ENFN

Wasatch Advisors’s Enfusion, Inc. ENFN Stock Holding History

Wasatch Advisors’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-792,083
Closed -$7.33M – 256
2024
Q1 		$7.33M Buy
792,083
+201,771
+34% +$1.78M 0.04% 181
2023
Q4 		$5.73M Hold
590,312
– – 0.03% 191
2023
Q3 		$5.3M Sell
590,312
-34,547
-6% -$328K 0.03% 196
2023
Q2 		$7.01M Buy
624,859
+73,641
+13% +$653K 0.04% 181
2023
Q1 		$5.79M Buy
551,218
+145,146
+36% +$1.6M 0.04% 199
2022
Q4 		$3.93M Buy
406,072
+99,926
+33% +$1.13M 0.03% 212
2022
Q3 		$3.78M Buy
+306,146
New +$3.73M 0.03% 211

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

Wasatch Advisors's ENFN Position: Q2 2024 in Review

Wasatch Advisors sold out of Enfusion, Inc. (ENFN) in Q2 2024, closing a stake of 792,083 shares — an estimated $7.33M sold.

Wasatch Advisors first reported a position in ENFN in Q3 2022 and held it in 7 quarters. The position peaked at $7.33M in Q1 2024. 101 funds tracked by Wall St. Rank hold ENFN as of Q2 2024.

  • Wasatch Advisors reported no remaining Enfusion, Inc. position as of Q2 2024 after selling out during the quarter.
  • Wasatch Advisors sold 792,083 Enfusion, Inc. shares in Q2 2024, an estimated $7.33M.
  • Wasatch Advisors first reported a position in Enfusion, Inc. in Q3 2022 and held it in 7 quarters.
  • Wasatch Advisors's Enfusion, Inc. position peaked at $7.33M in Q1 2024.
  • 101 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2024.

Based on Wasatch Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.